REQUEST A DEMO
Total
USD $0.00
Search more companies

111 Inc. (China)

Main Activities: Pharmacies and Drug Stores
Full name: 111 Inc. Profile Updated: October 22, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

The Copany operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is principally engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China.
It operates in two segments, B2C and B2B. The Company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services that include online consultation services and electronic prescription services to consumers. It offers prescription and over-the counter drugs, including western and traditional Chinese medicines; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices comprising bandages and thermometers; and personal care products consisting of skin care, birth control, sexual wellness products, and baby products. The Company also operates an online marketplace where third-party sellers can directly sell to pharmacies; provides online loan application services to the clients of 1 Pharmacy, which include pharmacies and wholesalers; and data and supply chain integration services. In addition, it offers warehousing, logistics, procurement, research and development, and consulting services; and software development and information technology support services. The Company operates offline retail pharmacies under the Yi Hao Pharmacy brand name in Guangdong, Guangzhou, Tianjin, and Kunshan. It serves pharmacies, pharmaceutical companies, medical professionals, and insurance companies.
History
2010 The Company was founded.
2013 The Company was incorporated under the laws of the Cayman Islands in May 2013.
2015 The Company was changed its name to New Peak Group in June 2015.
2018 The Company was changed its name to 111, Inc in April 2018 . On September 15, 2018, It ADSs commenced trading on Nasdaq under the symbol “YI.”

Headquarters
3Rd-4Th Floor, 295 Zuchongzhi Road, Pudong New Area
Shanghai; Shanghai; Postal Code: 201203

Contact Details: Purchase the 111 Inc. report to view the information.

Website: http://www.111.com.cn

Basic Information
Total Employees:
Purchase the 111 Inc. report to view the information.
Outstanding Shares:
Purchase the 111 Inc. report to view the information.
Financial Auditors:
Purchase the 111 Inc. report to view the information.
Incorporation Date:
December 09, 2025
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Chairman of the Executive Committee
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Outside Director
Ownership Details
Purchase this report to view the information.
21%
Purchase this report to view the information.
20.8%
Purchase this report to view the information.
5.1%
Purchase this report to view the information.
Subsidiaries
Anshun Joint Diagnosis And Treatment Technology Co., Ltd.
Anshun Southwest Internet Hospital Co., Ltd.
Chengdu Yihao Pharmacy Co., Ltd.
Company Performance
Financial values in the chart are available after 111 Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-3.13%
Total operating revenue
-3.1%
Operating profit (EBIT)
-96.48%
EBITDA
-96.6%
Net Profit (Loss) for the Period
-205.68%
Total assets
-11.21%
Total equity
-10.93%
Operating Profit Margin (ROS)
-0.1%
Net Profit Margin
-0.15%
Return on Equity (ROE)
1.35%
Debt to Equity Ratio
5.8%
Quick Ratio
0%
Cash Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?